• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶D抑制垂体神经内分泌肿瘤中的血管生成。

Cathepsin D Inhibits Angiogenesis in Pituitary Neuroendocrine Tumors.

作者信息

Fujiwara Ren, Ten Hirotomo, Chen Hui, Jiang Chuan-Lu, Oyama Ken-Ichi, Onoda Keisuke, Matsuno Akira

机构信息

Graduate School of Medicine, International University of Health and Welfare, 4-3 Kozunomori, Narita, Chiba 286-8686, Japan.

Department of Neurosurgery, International University of Health and Welfare, Narita Hospital, 852 Hatakeda, Narita, Chiba 286-8520, Japan.

出版信息

Acta Histochem Cytochem. 2022 Dec 28;55(6):203-211. doi: 10.1267/ahc.22-00098. Epub 2022 Dec 20.

DOI:10.1267/ahc.22-00098
PMID:36688139
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9840469/
Abstract

Prolactin and growth hormone can acquire anti-angiogenic properties after undergoing proteolytic cleavage by Cathepsin D and bone morphogenetic protein 1 (BMP-1) into fragments known as vasoinhibins. Little is known about the effect of vasoinhibins on angiogenesis through the involvement of key cleavage enzymes Cathepsin D and BMP-1 in pituitary neuroendocrine tumors (PitNETs, formerly pituitary adenomas). The purpose of this study was to investigate the mechanism of action of Cathepsin D and BMP-1 on angiogenesis in PitNETs compared with that of pro-angiogenic factors, including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor-2 (FGF2). A total of 43 patients were enrolled in a retrospective analysis and 22 samples were suitable for RNA extraction, including 16 nonfunctional PitNETs and six somatotroph tumors. The mRNA and protein levels of Cathepsin D, BMP-1, VEGF, and FGF2 were compared with those of von Willebrand factor, which was assessed to determine the vascularization of PitNETs. Cathepsin D and FGF2 were significantly correlated with vascularization in PitNETs. Both Cathepsin D and FGF2 are highly involved in angiogenesis in PitNETs, although the effect of Cathepsin D as an anti-angiogenic factor is dominant over that of FGF2 as a pro-angiogenic factor.

摘要

催乳素和生长激素在被组织蛋白酶D和骨形态发生蛋白1(BMP-1)进行蛋白水解切割后可获得抗血管生成特性,形成被称为血管抑制素的片段。关于血管抑制素通过关键切割酶组织蛋白酶D和BMP-1参与垂体神经内分泌肿瘤(PitNETs,以前称为垂体腺瘤)对血管生成的影响,人们了解甚少。本研究的目的是探讨与促血管生成因子(包括血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子-2(FGF2))相比,组织蛋白酶D和BMP-1在PitNETs血管生成中的作用机制。共有43例患者纳入回顾性分析,22个样本适合进行RNA提取,包括16例无功能PitNETs和6例生长激素瘤。将组织蛋白酶D、BMP-1、VEGF和FGF2的mRNA和蛋白水平与血管性血友病因子的水平进行比较,后者用于评估PitNETs的血管化情况。组织蛋白酶D和FGF2与PitNETs的血管化显著相关。组织蛋白酶D和FGF2均高度参与PitNETs的血管生成,尽管组织蛋白酶D作为抗血管生成因子的作用比FGF2作为促血管生成因子的作用更显著。

相似文献

1
Cathepsin D Inhibits Angiogenesis in Pituitary Neuroendocrine Tumors.组织蛋白酶D抑制垂体神经内分泌肿瘤中的血管生成。
Acta Histochem Cytochem. 2022 Dec 28;55(6):203-211. doi: 10.1267/ahc.22-00098. Epub 2022 Dec 20.
2
Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.基于临床和蛋白质组学的侵袭性和非侵袭性促生长激素垂体神经内分泌肿瘤的分子特征。
Neuroendocrinology. 2023;113(9):971-986. doi: 10.1159/000531200. Epub 2023 May 30.
3
Associations of Endocan, FGF2, and PDGF Expression with Pituitary Neuroendocrine Tumor (PitNET) Invasiveness.内皮糖蛋白、成纤维细胞生长因子2和血小板衍生生长因子表达与垂体神经内分泌肿瘤(PitNET)侵袭性的相关性。
Turk Neurosurg. 2022 Dec 20. doi: 10.5137/1019-5149.JTN.40216-22.4.
4
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.
5
Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors.非功能性垂体内分泌肿瘤的肿瘤血管生成与免疫微环境分析
J Clin Med. 2019 May 16;8(5):695. doi: 10.3390/jcm8050695.
6
Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors.转录组分析揭示侵袭性和非侵袭性垂体神经内分泌肿瘤之间的不同模式。
J Endocr Soc. 2024 Mar 1;8(5):bvae040. doi: 10.1210/jendso/bvae040. eCollection 2024 Mar 12.
7
Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.14q32.2 上的 DLK1/MEG3 基因座的功能特征揭示了垂体神经内分泌肿瘤的分化。
Aging (Albany NY). 2020 Dec 29;13(1):1422-1439. doi: 10.18632/aging.202376.
8
Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules.组织蛋白酶 D 是腺垂体血管抑制素生成的主要蛋白酶:裂解发生在泌乳素分泌颗粒内。
Endocrinology. 2009 Dec;150(12):5446-54. doi: 10.1210/en.2009-0390. Epub 2009 Oct 9.
9
Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.趋化因子调节垂体神经内分泌肿瘤的肿瘤微环境。
Acta Neuropathol Commun. 2019 Nov 8;7(1):172. doi: 10.1186/s40478-019-0830-3.
10
Co-occurrence of Pituitary Neuroendocrine Tumors (PitNETs) and Tumors of the Neurohypophysis.垂体神经内分泌肿瘤(PitNETs)与神经垂体肿瘤的共现
Endocr Pathol. 2021 Dec;32(4):473-479. doi: 10.1007/s12022-021-09677-y. Epub 2021 Jun 15.

本文引用的文献

1
Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel.类干细胞样人乳腺癌细胞在基质胶上引发血管生成拟态。
Acta Histochem Cytochem. 2018 Dec 20;51(6):173-183. doi: 10.1267/ahc.18041. Epub 2018 Dec 15.
2
Immunohistochemical Study of the Laminin α5 Chain and Its Specific Receptor, Basal Cell Adhesion Molecule (BCAM), in both Fetal and Adult Rat Pituitary Glands.层粘连蛋白α5链及其特异性受体基底细胞粘附分子(BCAM)在胎鼠和成鼠垂体中的免疫组织化学研究
Acta Histochem Cytochem. 2018 Oct 31;51(5):145-152. doi: 10.1267/ahc.18014. Epub 2018 Sep 13.
3
Notch Signaling and Maintenance of SOX2 Expression in Rat Anterior Pituitary Cells.
Notch信号通路与大鼠垂体前叶细胞中SOX2表达的维持
Acta Histochem Cytochem. 2017 Apr 27;50(2):63-69. doi: 10.1267/ahc.17002. Epub 2017 Apr 15.
4
Angiogenesis in pituitary adenomas: human studies and new mutant mouse models.垂体腺瘤中的血管生成:人体研究与新的突变小鼠模型
Int J Endocrinol. 2014;2014:608497. doi: 10.1155/2014/608497. Epub 2014 Nov 18.
5
Placental antiangiogenic prolactin fragments are increased in human and rat maternal diabetes.在人类和大鼠母体糖尿病中,胎盘抗血管生成催乳素片段增加。
Biochim Biophys Acta. 2014 Sep;1842(9):1783-93. doi: 10.1016/j.bbadis.2014.06.026. Epub 2014 Jun 28.
6
Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence.垂体腺瘤中血管内皮生长因子的过度表达与鞍外生长和复发有关。
Pituitary. 2013 Sep;16(3):370-7. doi: 10.1007/s11102-012-0434-4.
7
16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.16 kDa 泌乳素可减少血管生成,但不能抑制体内人乳腺癌肿瘤的生长。
Horm Cancer. 2010 Apr;1(2):71-9. doi: 10.1007/s12672-010-0012-z.
8
Endocrine gland derived-VEGF is down-regulated in human pituitary adenoma.内分泌腺衍生的 VEGF 在人垂体腺瘤中下调。
Anticancer Res. 2010 Oct;30(10):3981-6.
9
VEGF and CD31 association in pituitary adenomas.VEGF 与垂体腺瘤中的 CD31 相关。
Endocr Pathol. 2010 Sep;21(3):154-60. doi: 10.1007/s12022-010-9119-6.
10
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).在英国牛津郡的班伯里(Banbury,Oxfordshire,UK)进行的一项基于社区的垂体腺瘤患病率横断面研究。
Clin Endocrinol (Oxf). 2010 Mar;72(3):377-82. doi: 10.1111/j.1365-2265.2009.03667.x. Epub 2009 Jul 24.